Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2013 Dec 17;11051:20605-10. doi: 10.1073/pnas.1306328110.
Show Gene links
Show Anatomy links
Suppression of DNA-damage checkpoint signaling by Rsk-mediated phosphorylation of Mre11.
Chen C
,
Zhang L
,
Huang NJ
,
Huang B
,
Kornbluth S
.
???displayArticle.abstract???
Ataxia telangiectasia mutant (ATM) is an S/T-Q-directed kinase that is critical for the cellular response to double-stranded breaks (DSBs) in DNA. Following DNA damage, ATM is activated and recruited by the MRN protein complex [meiotic recombination 11 (Mre11)/DNA repair protein Rad50/Nijmegen breakage syndrome 1 proteins] to sites of DNA damage where ATM phosphorylates multiple substrates to trigger cell-cycle arrest. In cancer cells, this regulation may be faulty, and cell division may proceed even in the presence of damaged DNA. We show here that the ribosomal s6 kinase (Rsk), often elevated in cancers, can suppress DSB-induced ATM activation in both Xenopus egg extracts and human tumor cell lines. In analyzing each step in ATM activation, we have found that Rsk targets loading of MRN complex components onto DNA at DSB sites. Rsk can phosphorylate the Mre11 protein directly at S676 both in vitro and in intact cells and thereby can inhibit the binding of Mre11 to DNA with DSBs. Accordingly, mutation of S676 to Ala can reverse inhibition of the response to DSBs by Rsk. Collectively, these data point to Mre11 as an important locus of Rsk-mediated checkpoint inhibition acting upstream of ATM activation.
Abraham,
Cell cycle checkpoint signaling through the ATM and ATR kinases.
2001, Pubmed
Abraham,
Cell cycle checkpoint signaling through the ATM and ATR kinases.
2001,
Pubmed
Agarwal,
DNA double-strand break repair and chromosome translocations.
2006,
Pubmed
Buck,
C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival.
2001,
Pubmed
Bunone,
Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.
1996,
Pubmed
Clark,
The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.
2005,
Pubmed
Cohen,
Structural bioinformatics-based design of selective, irreversible kinase inhibitors.
2005,
Pubmed
Dalby,
Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK.
1998,
Pubmed
De Cesare,
Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene.
1998,
Pubmed
Di Virgilio,
PIKK-dependent phosphorylation of Mre11 induces MRN complex inactivation by disassembly from chromatin.
2009,
Pubmed
,
Xenbase
Eisinger-Mathason,
RSK in tumorigenesis: connections to steroid signaling.
2010,
Pubmed
Grove,
Regulation of an epitope-tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase.
1993,
Pubmed
,
Xenbase
Guo,
ATM activation in the presence of oxidative stress.
2010,
Pubmed
Hawley,
Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53.
1996,
Pubmed
Hurbin,
Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells.
2005,
Pubmed
Jackson,
Detecting, signalling and repairing DNA double-strand breaks.
2001,
Pubmed
Jackson,
The DNA-damage response in human biology and disease.
2009,
Pubmed
Kastan,
The many substrates and functions of ATM.
2000,
Pubmed
Kim,
Rsk-mediated phosphorylation and 14-3-3ɛ binding of Apaf-1 suppresses cytochrome c-induced apoptosis.
2012,
Pubmed
Kim,
Substrate specificities and identification of putative substrates of ATM kinase family members.
1999,
Pubmed
Kumareswaran,
Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability.
2012,
Pubmed
Lavin,
ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.
2007,
Pubmed
Lee,
Protein kinase Cdelta overexpression enhances radiation sensitivity via extracellular regulated protein kinase 1/2 activation, abolishing the radiation-induced G(2)-M arrest.
2002,
Pubmed
Lee,
Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex.
2004,
Pubmed
Li,
P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation.
2012,
Pubmed
Löbrich,
The impact of a negligent G2/M checkpoint on genomic instability and cancer induction.
2007,
Pubmed
Matsuoka,
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.
2000,
Pubmed
Paull,
A mechanistic basis for Mre11-directed DNA joining at microhomologies.
2000,
Pubmed
Ray-David,
RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance.
2013,
Pubmed
Rinehart,
Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer.
2004,
Pubmed
Ryves,
Activation of the PKC-isotypes alpha, beta 1, gamma, delta and epsilon by phorbol esters of different biological activities.
1991,
Pubmed
Sakata,
Ability to repair DNA double-strand breaks related to cancer susceptibility and radiosensitivity.
2007,
Pubmed
Sapkota,
BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo.
2007,
Pubmed
Sebolt-Leopold,
Targeting the mitogen-activated protein kinase cascade to treat cancer.
2004,
Pubmed
Sebolt-Leopold,
MEK inhibitors: a therapeutic approach to targeting the Ras-MAP kinase pathway in tumors.
2004,
Pubmed
Smith,
Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.
1999,
Pubmed
Smith,
Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.
2005,
Pubmed
Stracker,
The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together.
2004,
Pubmed
Sturgill,
Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II.
1988,
Pubmed
,
Xenbase
Wang,
Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells.
2012,
Pubmed
Warenius,
Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity.
2000,
Pubmed
Wu,
Control of Emi2 activity and stability through Mos-mediated recruitment of PP2A.
2007,
Pubmed
,
Xenbase
Xian,
Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival.
2009,
Pubmed
Xu,
Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation.
2002,
Pubmed
Zhang,
Ubiquitylation of p53 by the APC/C inhibitor Trim39.
2012,
Pubmed
Zhao,
RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation.
1995,
Pubmed
Zhou,
Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity.
2000,
Pubmed
